Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Zinc Finger Protein 265 (Zranb2) Peptid

Zranb2 Reaktivität: Human Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN987233

Kurzübersicht für Zinc Finger Protein 265 (Zranb2) Peptid (ABIN987233)

Target

ZNF265 (Zranb2) (Zinc Finger Protein 265 (Zranb2))

Spezies

Human

Quelle

  • 7
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-ZRANB2 antibody (Catalog #: ARP35779_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    ZNF265 (Zranb2) (Zinc Finger Protein 265 (Zranb2))

    Hintergrund

    ZRANB2 is a splice factor required for alternative splicing of SFRS10/TRA2B transcripts. It may interfere with constitutive 5'-splice site selection.

    Alias Symbols: DKFZp686J1831, DKFZp686N09117, ZIS, ZIS1, ZIS2, ZRANB2, ZNF265

    Protein Interaction Partner: EP300,SFRS12,SFRS17A,SMN2,SNRNP70,SRSF2,U2AF1,YY1,ZRANB2,ARRB1,SNRNP70,TRA2B,U2AF1,USP39

    Protein Size: 320

    Molekulargewicht

    36 kDa

    Gen-ID

    9406

    NCBI Accession

    NM_005455, NP_005446
Sie sind hier:
Chat with us!